Takeda clears key hurdle as investors back $59 billion Shire deal
2018-12-5 05:48 pm
Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.
Read The Rest at
Russia's Gazprom Neft sticking with plan to...
Unilever's Polman calls for trust in farewell...
You May Also Like
How to get back 'Other' storage on the iPhone...
FHP clears biker accused of leaving woman to...
Big Tech Companies Want to Help Get You Back in...
Reel Life: As Movies Reopen, Projectionist...
Prince Harry, Meghan Markle Sign Major Netflix...
Pentagon reaffirms Microsoft as winner of...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version